Table 2 Expression of circulating LncRNA and circRNA in colorectal cancer (CRC)
From: Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer
LncRNAs | ||||
|---|---|---|---|---|
| Â | Expression in CRC | Clinical relevance | Sample type | Ref |
DANCR | upregulated | Prognosis | Serum | [89] |
LncRNA-ATB | upregulated | Diagnosis / therapy | serum | [90] |
CCAT1 | upregulated | Diagnosis / therapy | Serum | [90] |
B3GALT5-AS1 | downregulated | Diagnosis | Serum | [91] |
MEG3 | downregulated | Prognosis | Serum | [92] |
SNHG11 | Upregulated | Diagnosis/therapy | Plasma | [93] |
LncRNA RP11909B2.1 | downregulated | Diagnosis | Serum | [94] |
circRNAs | ||||
hsa_circ_0001900, hsa_circ_0001178, Â hsa_circ_0005927 | Upregulated | Diagnosis | Plasma | [95] |
circ-CCDC66, circ-ABCC1, circ-STIL | Downregulated | Diagnosis | Plasma | [96] |
circ-VAPA | Upregulated | Diagnosis/therapy | Plasma | [97] |
hsa_circ_0082182, hsa_circ_0000370 | Upregulated | Diagnosis | Plasma | [98] |
hsa_circ_0035445 | Downregulated | Diagnosis | Plasma | [98] |
hsa_circ_0004831 | Upregulated | Prognosis | Serum | [99] |
hsa_circ_0007534 | Upregulated | Prognosis | Plasma | [100] |
hsa_circ_0001649 | Downregulated | Diagnosis | Serum | [101] |
hsa_circ_0002320 | Downregulated | Diagnosis/Prognosis | Plasma | [102] |
circ_PVT1, circ_001569 | Upregulated | Diagnostic/ Prognosis | Plasma | [103] |
hsa_circ_0004585 | Upregulated | Diagnostic | Plasma | [104] |